Logo image of NMTR

9 METERS BIOPHARMA INC (NMTR) Stock Analyst Ratings

NASDAQ:NMTR - Nasdaq - US6544052086 - Common Stock - Currency: USD

0.0722  -0.05 (-42.97%)

After market: 0.093 +0.02 (+28.81%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to NMTR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 10.58. This target is 14557.2% above the current price.
NMTR was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NMTR.
In the previous month the buy percentage consensus was at a similar level.
NMTR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

NMTR Historical Analyst RatingsNMTR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -56 -51 -46 -41 -36 -31 -26 -21 -16 -11 -6 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.070.7610.5810.5821.00 - 949.17% 14,557.20% 14,557.20% 28,985.87%

Related screens

NMTR Current Analyst RatingNMTR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-05-18 Citigroup Maintains Neutral -> Neutral
2023-03-20 Truist Securities Downgrade Buy -> Hold
2023-02-13 Citigroup Initiate Neutral
2022-11-10 BMO Capital Maintains Outperform
2022-09-27 Oppenheimer Maintains Outperform
2022-07-01 Maxim Group Downgrade Buy -> Hold
2022-06-22 BMO Capital Maintains Outperform
2022-06-22 Truist Securities Maintains Buy
2021-07-08 BMO Capital Initiate Outperform
2021-06-04 Citigroup Initiate Buy